Comparative Evaluation of the Powder and Tableting Properties of Regular and Direct Compression Hypromellose from Different Vendors.
alternate sourcing
compaction
compressibility
controlled release
density
direct compression
hypromellose
particle characteristics
tabletability
Journal
Pharmaceutics
ISSN: 1999-4923
Titre abrégé: Pharmaceutics
Pays: Switzerland
ID NLM: 101534003
Informations de publication
Date de publication:
17 Aug 2023
17 Aug 2023
Historique:
received:
28
06
2023
revised:
08
08
2023
accepted:
11
08
2023
medline:
26
8
2023
pubmed:
26
8
2023
entrez:
26
8
2023
Statut:
epublish
Résumé
Hypromellose, a widely used polymer in the pharmaceutical industry, is available in several grades, depending on the percentage of substitution of the methoxyl and hydroxypropyl groups and molecular weight, and in various functional forms (e.g., suitable for direct compression tableting). These differences can affect their physicomechanical properties, and so this study aims to characterise the particle size and mechanical properties of HPMC K100M polymer grades from four different vendors. Eight polymers (CR and DC grades) were analysed using scanning electron microscopy (SEM) and light microscopy automated image analysis particle characterisation to examine the powder's particle morphology and particle size distribution. Bulk density, tapped density, and true density of the materials were also analysed. Flow was determined using a shear cell tester. Flat-faced polymer compacts were made at five different compression forces and the mechanical properties of the compacts were evaluated to give an indication of the powder's capacity to form a tablet with desirable strength under specific pressures. The results indicated that the CR grades of the polymers displayed a smaller particle size and better mechanical properties compared to the DC grade HPMC K100M polymers. The DC grades, however, had better flow properties than their CR counterparts. The results also suggested some similarities and differences between some of the polymers from the different vendors despite the similarity in substitution level, reminding the user that care and consideration should be given when substitution is required.
Identifiants
pubmed: 37631368
pii: pharmaceutics15082154
doi: 10.3390/pharmaceutics15082154
pmc: PMC10459357
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
J Pharm Sci. 2009 May;98(5):1671-87
pubmed: 18781623
Int J Pharm. 2000 Apr 25;200(1):67-72
pubmed: 10845687
AAPS PharmSciTech. 2020 Jul 22;21(6):203
pubmed: 32699970
Drug Dev Ind Pharm. 2012 Oct;38(10):1159-70
pubmed: 22966909
Int J Pharm. 2019 Sep 10;568:118542
pubmed: 31330171
Int J Pharm. 2015;486(1-2):370-9
pubmed: 25841572
Pharm Dev Technol. 2011 Oct;16(5):542-8
pubmed: 20565228
Mol Pharm. 2017 Jun 5;14(6):2047-2055
pubmed: 28445056
Int J Pharm. 2021 Mar 1;596:120259
pubmed: 33486020
J Control Release. 2011 Aug 25;154(1):2-19
pubmed: 21497624
Ther Deliv. 2016 Aug;7(8):553-72
pubmed: 27444495
Drug Dev Ind Pharm. 2016 Nov;42(11):1877-86
pubmed: 27094181
J Pharm Sci. 2011 Jan;100(1):284-93
pubmed: 20572055
J Pharm Sci. 2003 Mar;92(3):494-504
pubmed: 12587111
Int J Pharm. 2012 May 10;427(2):345-53
pubmed: 22387216
J Pharm Pharmacol. 2005 May;57(5):533-46
pubmed: 15901342
J Pharm Sci. 2015 May;104(5):1563-74
pubmed: 25690940
ACS Omega. 2021 Oct 21;6(43):28598-28610
pubmed: 34746555
Int J Pharm. 2020 Jun 15;583:119343
pubmed: 32305364
Pharm Res. 1998 Jul;15(7):1122-30
pubmed: 9688070
J Pharm Sci. 2005 Mar;94(3):465-72
pubmed: 15696587
Colloids Surf B Biointerfaces. 2013 Apr 1;104:54-60
pubmed: 23298588
Int J Pharm. 2006 Mar 27;311(1-2):26-32
pubmed: 16431049